Vas Cular Assessment Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Vas Cular Assessment Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Vas Cular Assessment Study Today - Breaking & Trending Today

Proteomics International Laboratories Ltd (ASX:PIQ) Canagliflozin Lowers PromarkerD DKD Risk Prediction Scores

Published: May 3, 2023

Proteomics International Laboratories Ltd (ASX:PIQ) is pleased to announce results showing a significant reduction in the PromarkerD risk scores of patients with type 2 diabetes after taking the diabetes medicine canagliflozin.

Source: abnnewswire.net

Related Topics:

United StatesWestern AustraliaRichard LipscombeJanssen Research DevelopmentRj Lipscombe Proteomics InternationalProteomics International Laboratories LtdProteomics InternationalJanssen ResearchUniversity Of Western AustraliaCanagliflozin Lowers PromarkerdInternational Laboratories LtdClinical MedicinePrecision MedicineVascular Assessment StudyAustralasian Diabetes ConferenceEditorial BoardMedical SchoolFremantle HospitalSpring HouseVas Cular Assessment StudyPrint ThisPage ViewedHealth Pharm Generalproteomics International Laboratories LtdAsx Piq